title: [Methadone and new antiretroviral drugs. Results of therapeutic follow-up].
authors.affiliation: Département de Soins aux Toxicomanes, Clinique Liberté, CH Paul-Guiraud, Villejuif.
authors.forename: D
authors.initials: D
authors.lastname: Touzeau
authors.forename: P
authors.initials: P
authors.lastname: Beauverie
authors.forename: J
authors.initials: J
authors.lastname: Bouchez
authors.forename: N
authors.initials: N
authors.lastname: Poisson
authors.forename: Y
authors.initials: Y
authors.lastname: Edel
authors.forename: M C
authors.initials: MC
authors.lastname: Dessalles
authors.forename: J
authors.initials: J
authors.lastname: Lherm
authors.forename: V
authors.initials: V
authors.lastname: Furlan
authors.forename: B
authors.initials: B
authors.lastname: Lagarde
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D001682:Biological Availability; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008691:Methadone / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D008691:Methadone